Massachusetts Financial Services’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Sell
407,373
-31
-0% -$1K ﹤0.01% 711
2025
Q4
$14.1M Sell
407,404
-34,994
-8% -$1.24M ﹤0.01% 688
2025
Q3
$16.1M Sell
442,398
-3,369
-0.8% -$114K 0.01% 656
2025
Q2
$14M Sell
445,767
-14,984
-3% -$465K ﹤0.01% 654
2025
Q1
$13.7M Buy
460,751
+1,706
+0.4% +$51.2K ﹤0.01% 633
2024
Q4
$13.5M Sell
459,045
-39,176
-8% -$1.24M ﹤0.01% 636
2024
Q3
$15.5M Buy
498,221
+107,656
+28% +$3.92M ﹤0.01% 620
2024
Q2
$13.2M Buy
390,565
+79,444
+26% +$4.05M ﹤0.01% 619
2024
Q1
$20.2M Sell
311,121
-1,487
-0.5% -$102K 0.01% 576
2023
Q4
$21.4M Buy
312,608
+261
+0.1% +$13.6K 0.01% 565
2023
Q3
$16.2M Sell
312,347
-49,616
-14% -$2.94M 0.01% 589
2023
Q2
$21.7M Sell
361,963
-3,619
-1% -$207K 0.01% 546
2023
Q1
$18.1M Sell
365,582
-352
-0.1% -$19.8K 0.01% 566
2022
Q4
$20.9M Buy
365,934
+1,196
+0.3% +$67.3K 0.01% 545
2022
Q3
$17.1M Buy
364,738
+24,796
+7% +$1.18M 0.01% 571
2022
Q2
$12.7M Sell
339,942
-2,536
-0.7% -$82.4K ﹤0.01% 592
2022
Q1
$10.2M Buy
342,478
+9,398
+3% +$237K ﹤0.01% 633
2021
Q4
$11.4M Sell
333,080
-2,432
-0.7% -$88K ﹤0.01% 652
2021
Q3
$12.4M Buy
335,512
+238,286
+245% +$8.04M ﹤0.01% 658
2021
Q2
$3.8M Sell
97,226
-276
-0.3% -$10.7K ﹤0.01% 728
2021
Q1
$4.15M Buy
+97,502
New +$4.34M ﹤0.01% 707

Other funds holding IMCR